Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Gerald D. Frenkel"'
Autor:
Lorna Rodriguez-Rodriguez, Paula B. Caffrey, Muthu N. Kumaran, Mira Hellmann, Wilberto Nieves-Neira, Brian Buckley, Michael P. Kane, Murugesan Gounder, Darlene Gibbon, Gerald D. Frenkel, Mihae Song, Weichung Shih, Ami Vaidya
Publikováno v:
Gynecologic oncology. 150(3)
Purpose Preclinical studies performed in our laboratory have shown that high-dose selenium inhibits the development of carboplatin drug resistance in an ovarian cancer mouse xenograft model. Based on these data, as well as the potential serious toxic
Publikováno v:
In vivo (Athens, Greece). 30(6)
Background/aim To study the prevention of chemotherapy resistance, we have previously designed models of drug-resistant ovarian cancer. We here report an in vivo model of cisplatin-resistant small cell lung cancer (SCLC). Materials and methods Mice b
Publikováno v:
Cancer Letters. 136:47-52
Exposure of A2780 human ovarian tumor cells to a low concentration of melphalan in vitro for 7 days resulted in the development of melphalan resistance. This resistance was not a stable characteristic of the cells since it was lost after 2 weeks in c
Publikováno v:
Biological Trace Element Research. 65:187-195
Exposure of A2780 human ovarian tumor cells to a low concentration of melphalan in vitro for 7 d results in the development of melphalan resistance, which is dependent on elevated cellular levels of glutathione and glutathione S-transferase. The incl
Publikováno v:
Biological Trace Element Research. 62:123-134
We previously reported that exposure of HeLa cells to selenite for 2 h results in a decrease in their ability to attach to fibronectin (Yan and Frenkel, Cancer Res. 52, 5803-5807 [1992]), as well as a decrease in the level of fibronectin receptor (al
Autor:
Paula B, Caffrey, Gerald D, Frenkel
Publikováno v:
Anticancer research. 33(10)
We have been exploring a prevention approach to the problem of drug resistance which develops during ovarian cancer chemotherapy. We have previously described an in vivo model of the development of resistance to the chemotherapy drug cisplatin in xen
Selenite enhances and prolongs the efficacy of cisplatin treatment of human ovarian tumor xenografts
Autor:
Paula B, Caffrey, Gerald D, Frenkel
Publikováno v:
In vivo (Athens, Greece). 26(4)
Our earlier studies on ovarian tumor xenografts provide evidence that co-treatment with selenite prevents the development of resistance to single-treatment using the drug cisplatin. However, these studies did not reflect the repetitive schedule of cl
Autor:
Gerald D. Frenkel, Lin Yan
Publikováno v:
Biological Trace Element Research. 46:79-89
Incubation of cells with selenite, under conditions in which there is no effect on cell viability, results in a decrease in the rate of their subsequent attachment to extracellular matrix proteins such as fibronectin (1). The attachment was inhibited
Autor:
Yuhong Gong, Gerald D. Frenkel
Publikováno v:
Cancer Letters. 78:195-199
Pre-exposure of HeLa or NIH:OVCAR-3 cells to selenite resulted in a dose-dependent decrease in the ability of the cells to invade a layer of Matrigel, a reconstituted basement membrane preparation. In contrast, selenate, selenomethionine and sulfite
Autor:
Christina MacVicar, Gerald D. Frenkel
Publikováno v:
Biological Trace Element Research. 39:139-147
The effect of cell density on the sensitivity of tumor cells to selenite has been examined. The inhibitory effect of selenite on cellular DNA and RNA synthesis was significantly greater in higher density cultures of HeLa cells and A2780 ovarian tumor